These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10026488)

  • 21. Infections in PD.
    Bernardini J
    ANNA J; 1996 Apr; 23(2):110. PubMed ID: 8716854
    [No Abstract]   [Full Text] [Related]  

  • 22. Fungal peritonitis in patients on peritoneal dialysis: twenty five years of experience in a teaching hospital in Argentina.
    Predari SC; de Paulis AN; Verón D; Zucchini A; Santoianni JE
    Rev Argent Microbiol; 2007; 39(4):213-7. PubMed ID: 18390154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does endoluminal brushing eliminate the need for catheter removal in peritoneal dialysis patients with persistent peritonitis?
    Aksu N; Yavascan O; Kara OD; Erdogan H; Kangin M
    Adv Perit Dial; 2003; 19():260-3. PubMed ID: 14763075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for intervention in and prevention of biofilm-related infection in peritoneal dialysis patients.
    Dasgupta MK
    Adv Perit Dial; 2003; 19():195-7. PubMed ID: 14763061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peritoneal dialysis. Complications].
    Genestier S; Gross N
    Soins; 1997 Dec; (621):32-5. PubMed ID: 9479217
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives.
    Qamar M; Sheth H; Bender FH; Piraino B
    Adv Perit Dial; 2009; 25():76-9. PubMed ID: 19886322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection?
    Kotsanas D; Polkinghorne KR; Korman TM; Atkins RC; Brown F
    Nephrology (Carlton); 2007 Jun; 12(3):239-45. PubMed ID: 17498118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of tissue plasminogen activator in peritoneal dialysis catheters: a literature review and one center's experience.
    Zorzanello MM; Fleming WJ; Prowant BE
    Nephrol Nurs J; 2004; 31(5):534-7. PubMed ID: 15518255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreasing peritonitis infection rates.
    Alcaraz M; Brzostowicz M; Moran J
    Nephrol Nurs J; 2008; 35(4):421-3. PubMed ID: 18783006
    [No Abstract]   [Full Text] [Related]  

  • 30. Peritonitis in continuous cycling peritoneal dialysis.
    Diaz-Buxo JA; Crawford TL
    Adv Perit Dial; 2002; 18():161-4. PubMed ID: 12402611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Computerization of care and surveillance of nosocomial infections].
    Broussin P; Grison P; Neveu S
    Soins; 1999 Sep; (638):44-6. PubMed ID: 10876597
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing and training patients on peritoneal dialysis in their own homes can influence better practice.
    Ozturk S; Yucel L; Guvenc S; Ekiz S; Kazancioglu R
    J Ren Care; 2009 Sep; 35(3):141-6. PubMed ID: 19689696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: the influence of peritoneal dialysis systems and solutions on the incidence of peritonitis and catheter-related infections.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S41-4. PubMed ID: 15469555
    [No Abstract]   [Full Text] [Related]  

  • 35. Three year prospective follow up of the peritoneal access.
    Reyero A; Galera A
    EDTNA ERCA J; 1998; 24(4):32-5. PubMed ID: 10222914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of peritonitis frequency on the effectiveness of peritoneal dialysis and effect of peritoneal dialysis effectiveness on the frequency of peritonitis].
    Jakić M
    Acta Med Croatica; 2003; 57(1):43-7. PubMed ID: 12876862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consequences of peritonitis episodes appearing late during peritoneal dialysis (PD) in patients able to continue PD.
    Selgas R; Paiva A; Bajo MA; Cirugeda A; Aguilera A; Díaz C; Hevia C
    Adv Perit Dial; 1998; 14():168-72. PubMed ID: 10649718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Driving down infection.
    O'Dowd A
    Nurs Times; 2005 Aug 9-15; 101(32):22-3. PubMed ID: 16119583
    [No Abstract]   [Full Text] [Related]  

  • 40. Infections in dialysis patients.
    Arduino MJ; Lucero C; Patel P
    Nephrol News Issues; 2008 Feb; 22(2):48-50, 53, 55-7 passim. PubMed ID: 18326462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.